N-[(1R,10R,11S,24S)-10,13-dihydroxy-20-[(3-hydroxyquinoline-2-carbonyl)amino]-2,12,15,25-tetramethyl-11,24-bis(methylsulfanylmethyl)-3,6,16,19,23,26-hexaoxo-9,22,28,29-tetrathia-2,5,12,15,18,25-hexazabicyclo[12.12.4]triacontan-7-yl]-3-hydroxyquinoline-2-carboxamide

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 大环内酰胺类
• 英文名称: N-[(1R,10R,11S,24S)-10,13-dihydroxy-20-[(3-hydroxyquinoline-2-carbonyl)amino]-2,12,15,25-tetramethyl-11,24-bis(methylsulfanylmethyl)-3,6,16,19,23,26-hexaoxo-9,22,28,29-tetrathia-2,5,12,15,18,25-hexazabicyclo[12.12.4]triacontan-7-yl]-3-hydroxyquinoline-2-carboxamide
• 化学式: C₄₈H₆₀N₁₀O₁₂S₆
• 分子量: 1161.5
• InChiKey: YUACFTGOIAZZJF-ONJLVAKWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  76
• 可旋转键数：
  8
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  456
• 氢给体数：
  8
• 氢受体数：
  21

文献信息

• Factor IX: Remodeling and Glycoconjugation of Factor IX
  申请人：Novo Nordisk A/S

  公开号：US20140170728A1

  公开（公告）日：2014-06-19

  The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.